Christopher W. Fulton

Array ( [id] => 1401010 [patent_doc_number] => 06531577 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-11 [patent_title] => 'von Willebrand factor (vWF)-containing preparation, process for preparing vWF-containing preparations, and use of such preparations' [patent_app_type] => B1 [patent_app_number] => 09/210338 [patent_app_country] => US [patent_app_date] => 1998-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8514 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/531/06531577.pdf [firstpage_image] =>[orig_patent_app_number] => 09210338 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1308316 [patent_doc_number] => 06617425 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-09 [patent_title] => 'Peptides' [patent_app_type] => B1 [patent_app_number] => 09/202098 [patent_app_country] => US [patent_app_date] => 1998-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 9291 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/617/06617425.pdf [firstpage_image] =>[orig_patent_app_number] => 09202098 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7638518 [patent_doc_number] => RE037686 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2002-04-30 [patent_title] => 'Azahydroxybenzotriazoles and derivatives thereof for peptide coupling reactions' [patent_app_type] => E1 [patent_app_number] => 09/213298 [patent_app_country] => US [patent_app_date] => 1998-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11063 [patent_no_of_claims] => 123 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/037/RE037686.pdf [firstpage_image] =>[orig_patent_app_number] => 09213298 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4355621 [patent_doc_number] => 06291640 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-18 [patent_title] => 'Peptidomimetic inhibitors of the human cytomegalovirus protease' [patent_app_type] => 1 [patent_app_number] => 9/171554 [patent_app_country] => US [patent_app_date] => 1998-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 37709 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 365 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/291/06291640.pdf [firstpage_image] =>[orig_patent_app_number] => 171554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4054130 [patent_doc_number] => 05932696 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-03 [patent_title] => 'Solid phase preparation of amines' [patent_app_type] => 1 [patent_app_number] => 9/168042 [patent_app_country] => US [patent_app_date] => 1998-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6080 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 194 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/932/05932696.pdf [firstpage_image] =>[orig_patent_app_number] => 168042 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1586957 [patent_doc_number] => 06359113 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-19 [patent_title] => 'Protective group, compound protected by said group and device for grafting the protective group on the compound to protect it' [patent_app_type] => B1 [patent_app_number] => 09/162777 [patent_app_country] => US [patent_app_date] => 1998-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16538 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/359/06359113.pdf [firstpage_image] =>[orig_patent_app_number] => 09162777 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4187589 [patent_doc_number] => 06160100 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-12 [patent_title] => 'Treatment for wilt diseases of trees' [patent_app_type] => 1 [patent_app_number] => 9/160246 [patent_app_country] => US [patent_app_date] => 1998-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 5 [patent_no_of_words] => 11679 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/160/06160100.pdf [firstpage_image] =>[orig_patent_app_number] => 160246 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1304463 [patent_doc_number] => 06620916 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-16 [patent_title] => 'Modified physiologically active proteins and medicinal compositions containing the same' [patent_app_type] => B1 [patent_app_number] => 09/068987 [patent_app_country] => US [patent_app_date] => 1998-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 17 [patent_no_of_words] => 12436 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 180 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/620/06620916.pdf [firstpage_image] =>[orig_patent_app_number] => 09068987 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6472638 [patent_doc_number] => 20020151460 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-17 [patent_title] => 'REGULATION OF EPITHELIAL TISSUE BY HEDGEHOG-LIKE POLYPEPTIDES, AND FORMULATIONS AND USES RELATED THERETO' [patent_app_type] => new [patent_app_number] => 09/151999 [patent_app_country] => US [patent_app_date] => 1998-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 32223 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0151/20020151460.pdf [firstpage_image] =>[orig_patent_app_number] => 09151999 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1120064 [patent_doc_number] => 06797698 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-09-28 [patent_title] => 'Method of treating prolonged critical illness and other conditions having a similar neuroendocrine pattern' [patent_app_type] => B1 [patent_app_number] => 09/146205 [patent_app_country] => US [patent_app_date] => 1998-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10081 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/797/06797698.pdf [firstpage_image] =>[orig_patent_app_number] => 09146205 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1533701 [patent_doc_number] => 06410684 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-25 [patent_title] => 'Serine protease inhibitors' [patent_app_type] => B1 [patent_app_number] => 09/142110 [patent_app_country] => US [patent_app_date] => 1998-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17119 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 583 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/410/06410684.pdf [firstpage_image] =>[orig_patent_app_number] => 09142110 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4181163 [patent_doc_number] => 06037447 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-14 [patent_title] => 'Glycopeptide compounds' [patent_app_type] => 1 [patent_app_number] => 9/125496 [patent_app_country] => US [patent_app_date] => 1998-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9426 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 606 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/037/06037447.pdf [firstpage_image] =>[orig_patent_app_number] => 125496 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4370053 [patent_doc_number] => 06274703 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-14 [patent_title] => 'Method of cell surface activation and inhibition' [patent_app_type] => 1 [patent_app_number] => 9/138721 [patent_app_country] => US [patent_app_date] => 1998-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 14114 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/274/06274703.pdf [firstpage_image] =>[orig_patent_app_number] => 138721 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4370100 [patent_doc_number] => 06274705 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-14 [patent_title] => 'Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides' [patent_app_type] => 1 [patent_app_number] => 9/137998 [patent_app_country] => US [patent_app_date] => 1998-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12008 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 154 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/274/06274705.pdf [firstpage_image] =>[orig_patent_app_number] => 137998 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4239441 [patent_doc_number] => 06080721 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-27 [patent_title] => 'Pulmonary delivery of active fragments of parathyroid hormone' [patent_app_type] => 1 [patent_app_number] => 9/128401 [patent_app_country] => US [patent_app_date] => 1998-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 3909 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/080/06080721.pdf [firstpage_image] =>[orig_patent_app_number] => 128401 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1377640 [patent_doc_number] => 06559127 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-06 [patent_title] => 'Compounds which inhibit leukocyte adhesion mediated by VLA-4' [patent_app_type] => B1 [patent_app_number] => 09/127533 [patent_app_country] => US [patent_app_date] => 1998-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37674 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/559/06559127.pdf [firstpage_image] =>[orig_patent_app_number] => 09127533 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1581507 [patent_doc_number] => 06423688 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-23 [patent_title] => 'Dipeptide and related compounds which inhibit leukocyte adhesion mediated by VLA-4' [patent_app_type] => B1 [patent_app_number] => 09/126329 [patent_app_country] => US [patent_app_date] => 1998-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32534 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 616 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/423/06423688.pdf [firstpage_image] =>[orig_patent_app_number] => 09126329 [rel_patent_id] =>[rel_patent_doc_number] =>)